These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. Lanza GM; Winter P; Caruthers S; Schmeider A; Crowder K; Morawski A; Zhang H; Scott MJ; Wickline SA Curr Pharm Biotechnol; 2004 Dec; 5(6):495-507. PubMed ID: 15579039 [TBL] [Abstract][Full Text] [Related]
6. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Aime S; Barge A; Cabella C; Crich SG; Gianolio E Curr Pharm Biotechnol; 2004 Dec; 5(6):509-18. PubMed ID: 15579040 [TBL] [Abstract][Full Text] [Related]
7. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. Ho C; Hitchens TK Curr Pharm Biotechnol; 2004 Dec; 5(6):551-66. PubMed ID: 15579044 [TBL] [Abstract][Full Text] [Related]
8. Monitoring dynamic alterations in calcium homeostasis by T1-mapping manganese-enhanced MRI (MEMRI) in the early stage of small intestinal ischemia-reperfusion injury. Zhao DW; Zhang LT; Cheng HY; Zhang YL; Min JY; Xiao HL; Wang Y NMR Biomed; 2015 Aug; 28(8):958-66. PubMed ID: 26086648 [TBL] [Abstract][Full Text] [Related]
10. Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain. Brunnquell CL; Hernandez R; Graves SA; Smit-Oistad I; Nickles RJ; Cai W; Meyerand ME; Suzuki M Contrast Media Mol Imaging; 2016 Sep; 11(5):371-380. PubMed ID: 27396476 [TBL] [Abstract][Full Text] [Related]
11. Indirectly probing Ca(2+) handling alterations following myocardial infarction in a murine model using T(1)-mapping manganese-enhanced magnetic resonance imaging. Waghorn B; Schumacher A; Liu J; Jacobs S; Baba A; Matsuda T; Yanasak N; Hu TC Magn Reson Med; 2011 Jan; 65(1):239-49. PubMed ID: 20872864 [TBL] [Abstract][Full Text] [Related]
12. Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection. Hou W; Toh TB; Abdullah LN; Yvonne TWZ; Lee KJ; Guenther I; Chow EK Nanomedicine; 2017 Apr; 13(3):783-793. PubMed ID: 28003120 [TBL] [Abstract][Full Text] [Related]
13. A new manganese-based oral contrast agent (CMC-001) for liver MRI: pharmacological and pharmaceutical aspects. Jørgensen JT; Rief M; Brismar TB; Wagner M; Albiin N Acta Radiol; 2012 Sep; 53(7):707-13. PubMed ID: 22821959 [TBL] [Abstract][Full Text] [Related]
14. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies. Bertin A; Steibel J; Michou-Gallani AI; Gallani JL; Felder-Flesch D Bioconjug Chem; 2009 Apr; 20(4):760-7. PubMed ID: 19368343 [TBL] [Abstract][Full Text] [Related]
15. Engineering an effective Mn-binding MRI reporter protein by subcellular targeting. Bartelle BB; Mana MD; Suero-Abreu GA; Rodriguez JJ; Turnbull DH Magn Reson Med; 2015 Dec; 74(6):1750-7. PubMed ID: 25522343 [TBL] [Abstract][Full Text] [Related]